Tag: <span>FDA</span>

Home / FDA
Post

Ketamine works great for depression and other conditions, and costs $10/dose; the new FDA-approved “ketamine” performs badly in trials and costs a fortune

Ketamine is a sedative first synthesized in 1962; its patents have long elapsed and it costspennies; it has many uses and is also sold illegally for use as a recreational drug, but in recent years it has been used with remarkable efficacy as a treatment for a variety of disorders, including depression, anxiety, and chronic pain (I have...

Post

FDA warns Americans not to buy drugs from Canadian company

CanaRx sells common prescription medicines at a lower cost to hundreds of public and private employer programs in the United States, including city and county governments trying to save money, The New York Times reported. The company says it provides high-quality medications from Canada, Australia, and Britain, but the FDA says that is not always the case. “Operations like CanaRx use their names...

Post

FDA Warns of Higher Risk for Death With Gout Drug Febuxostat (Uloric)

The US Food and Drug Administration (FDA) has added a boxed warning to the label for gout drug febuxostat (Uloric, Takeda) on the basis of results of a large post marketing safety study. The FDA has concluded that there is an increased risk for death with febuxostat compared to another gout medicine, allopurinol (multiple brands). “This conclusion is based on our in-depth review of results from a safety clinical trial that found an...

Post

Trump Administration Brags About Quick Generic Drug Approvals. But Hundreds Of Them Aren’t For Sale.

Meanwhile, brand-name drug makers are raising prices at 10 percent per year. The Trump administration has been trumpeting a huge increase in generic drug approvals by the Food and Drug Administration in the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices. But nearly half of those...

Post

Teva’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment

Teva Pharmaceutical, based in Israel, landed the first FDA approval for a digital inhaler with built-in sensors. The ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder is indicated for people suffering from asthma & COPD as a way of preventing and treating bronchospasm, a tightening of the muscles that line the airways. The ProAir Digihaler...

Post

Certain antibiotics may cause aortic aneurysm, FDA warns

(CNN)The US Food and Drug Administration warned on Thursday that the benefits of fluoroquinolone antibiotics do not outweigh the risks — which include aortic aneurysm — for certain patients, according to the latest research. The research is based on reports of patient problems and on studies published between 2015 and 2018. Fluoroquinolone antibiotics are often...

Post

FDA approves drugs for treatment of two rare blood diseases

(HealthDay)—Two drugs have been approved by the U.S. Food and Drug Administration for the treatment of rare blood diseases, the agency announced Friday. Elzonris (tagraxofusp-erzs) infusion was granted the first approval for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and children aged 2 years and older. Researchers investigated the efficacy of...

Post

GenMark Fungal Blood Culture Test Clears FDA

NEW YORK (GenomeWeb) – GenMark Diagnostics announced today it has received 510(k) clearance from the US Food and Drug Administration for a molecular diagnostic panel assay to detect fungal pathogens from blood cultures of patients with suspected blood stream infections. The test is called the ePlex Blood Culture Identification Fungal Pathogen (BCID-FP) Panel. It runs...

Post

FDA Accepts BrainStorm’s NurOwn® IND Application for Progressive Multiple Sclerosis

U.S. Phase 2 Study to Begin in First Quarter of 2019 NEW YORK, Dec. 17, 2018 — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application...